Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Celloss Biotech Logo
Celloss Biotech Growth Score
82
CB Rank
2113949
Heat Score
31
Celloss Biotech develops antibodies for the treatment of fibrotic diseases related to inflammatory proteins secreted outside cells.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea1-10 celros.com
Biotechnology
Medical
Pharmaceutical
Overview

Celloss Biotech
Growth Score
82
Heat Score
31

Growth Score82
-4 pts
in past quarter
Heat Score 31
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Celloss Biotech

CB Rank
2113949
Celloss Biotech develops antibodies for the treatment of fibrotic diseases related to inflammatory proteins secreted outside cells.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea1-10 celros.com
Biotechnology
Medical
Pharmaceutical

Details

Legal Name Celloss Biotech Co., Ltd.
Operating Status Active
Company Type For Profit
Phone Number +82 070 4651 4380
Contact Email foever23@celros.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Antibody Therapeutics for Fibrotic and Inflammatory Diseases
Development of antibodies targeting inflammatory proteins secreted outside cells to treat fibrotic diseases.
Nox Inhibitor Synthetic Drug Development
Development of synthetic drugs that inhibit Nox enzymes involved in inflammatory diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Monthly Web Visits

406

Active Website Tech Count

9Celloss Biotech is actively using 9 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Google Font API.
Sub-Organizations
Frequently Asked Questions

Where is Celloss Biotech's headquarters? Celloss Biotech is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who are Celloss Biotech's competitors? Alternatives and possible competitors to Celloss Biotech may include Nuvig Therapeutics, Augustine Therapeutics, and  Eikonizo Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|